hi George;
I'm posting the news release for all interested parties:
MONTREAL, March 25 /PRNewswire/ -- Park Meditech Inc. (the "Company") announced its results for the six
months ended January 31st, 1997:
-- Revenues were $CDN 4,635,426, compared with $CDN 3,149,835 in 1996.
-- Net loss was $CDN 5,019,871 compared to $CDN 4,925,297 in 1996.
-- Net loss per common share was $CDN 0.12 compared with $0.18 in 1996.
C. Richard Mullen, President and CEO stated, "With most of our operational reorganization behind us, we are
continuing to pursue new business opportunities, and to ship our scheduled backlog. Additionally, we continue to move
ahead in the development of new products -- as previously announced, our Modular Coded Aperture Technology has
recently received the U.S. Food and Drug Administration's 510(k) approval. We are also actively seeking a strategic
partner that can assist the company in maximizing its technology within our market."
Park Meditech is a medical technology company that specializes in nuclear medicine imaging systems. It has developed
and patented a totally digital imaging system which offers significantly improved diagnostic capabilities over the entire
energy range. The Company operates through its subsidiaries in developing, manufacturing and marketing imaging
technologies, equipment and related computer systems. SOURCE Park Meditech, Inc.
In my opinion, where the release indicates that PM is looking for
a 'strategic partner' it must mean a partner with the ability to market PM's products. This does indeed sound good for investors.
Sergio |
